Swiperx Secures Us$27 Million In Series B Funding To Accelerate Growth Across Southeast Asia

May 23, 2022•about 3 years ago

Amount Raised

$27 Million

Round Type

series b

Description

SwipeRx (formerly mClinica Pharmacy Solutions), Southeast Asia's (SEA) leading platform for pharmacies, announced it has secured a Series B round of US$27 million in equity and debt to accelerate growth across SEA. The round was led by Indonesia's MDI Ventures, with participation from global investors, Bill & Melinda Gates Foundation, Johnson & Johnson Impact Ventures, SIG and existing investors.

Company Information

Company

Swipe Rx

About

SwipeRx has the largest retail purchasing network, national logistics capabilities, financing options and fully integrated B2B stack for pharmacies to leverage. Singapore-based mClinica Pharmacy Solutions recently rebranded to SwipeRx, the name of its flagship app and has acquired more than 235,000 pharmacy professionals and 45,000 pharmacies across SEA to-date.With a strong presence across Indonesia, The Philippines, Vietnam, Malaysia, Thailand and Cambodia, SwipeRx is ready to grow its network of pharmacies, expand their specialised healthcare logistics to fulfil B2B commerce, accelerate technological innovation and recruit talent across SEA.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Swiperx Secures Us$27 Million In Series B Funding To Accelerate Growth Across Southeast Asia

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information